CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

⌕
Regions
Topics
Saved views:
Save your current filters to revisit or share.
1 stories
🇧🇷 G1 (PT)
National & Local

Anvisa analyzes eight medications with semaglutide; see what changes with the patent expiration

Brazil's health regulatory agency Anvisa is currently reviewing eight semaglutide-based drug applications following the recent patent expiration of the popular medications Ozempic and Wegovy.

Mar 21 • 03:01 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.